Skip to main content

Your search for “CIRM” returned 68 results

ALS Study Reveals Role of RNA-Binding Proteins

October 20, 2016

Although only 10 percent of amyotrophic lateral sclerosis (ALS) cases are hereditary, a significant number of them are caused by mutations that affect proteins that bind RNA, a type of genetic material. University of California San Diego School of Medicine researchers studied several ALS cases with a mutation in a…

Extra Fingers and Hearts: Pinpointing Changes to Our Genetic Instructions That Disrupt Development

February 6, 2024

UC San Diego scientists have shown that they can now predict which single-letter changes to the DNA within our genomes will alter genetic instructions and disrupt development, leading to changes such as the growth of extra digits and hearts.

Common RNA Pathway Found in ALS and Dementia

October 1, 2012

Two proteins previously found to contribute to ALS, also known as Lou Gehrig’s disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.

UC San Diego Develops First-In-Kind Protocol for Creating ‘Wired Miniature Brains’

June 10, 2024

Researchers have developed — and shared — a process for creating brain cortical organoids — essentially miniature artificial brains with functioning neural networks

In Multiple Myeloma, High Levels of Enzyme ADAR1 are Associated with Reduced Survival

December 5, 2017

Using a database of multiple myeloma patient samples and information, researchers at University of California San Diego School of Medicine found that high ADAR1 levels correlate with reduced survival rates. They also determined that blocking the enzyme reduces multiple myeloma regeneration in experimental models derived from patient cancer cells.

Small Molecule Drug Reverses ADAR1-induced Cancer Stem Cell Cloning Capacity

February 16, 2023

UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.

‘A Tornado at the Front Door, a Tsunami at the Back Door’

January 23, 2020

…the Cystinosis Research Foundation, California Institute for Regenerative Medicine (CIRM), and National Institutes of Health. She receives additional support from the Sanford Stem Cell Clinical Center and CIRM-funded Alpha Stem Cell Clinic at UC San Diego Health, and AVROBIO.

Lab-Grown Human Brain Organoids Mimic an Autism Spectrum Disorder, Help Test Treatments

December 8, 2020

UC San Diego researchers used brain organoids to identify two drug candidates that counteract the genetic deficiencies that cause Rett syndrome, a rare form of autism spectrum disorder.

How Old Is Your Dog in Human Years? Scientists Develop Better Method than ‘Multiply by 7’

July 2, 2020

…Institute for Regenerative Medicine (CIRM), and Maxine Adler Endowed Chair Funds. An earlier version of this paper was shared as a preprint on BioRxiv on November 19, 2019, prior to peer-review and publication in Cell Systems. Disclosure: Trey Ideker is co-founder of Data4Cure, Inc., is on the Scientific Advisory Board,…

Five UC San Diego Jacobs School of Engineering Graduate Students Named 2013 Siebel Scholars

September 19, 2012

Five University of California, San Diego graduate students pursuing research at the intersection of bioengineering, medicine and biology are among the 85 recipients of 2013 Siebel Scholars awards, announced by the Siebel Scholars Foundation on September 10, 2012.

Category navigation with Social links